Title: “NOVEL ANTIPROLIFERATIVE PROTEIN FROM BACILLUS THURINGIENSIS VAR. THURINGIENSIS”.
Summary: Cancer therapy and treatment of neoplastic cell such as myeloid cell, b lymphoid cells,T lymphoid cell, erythroblastoid cell, breast tumor cells, ovarian tumor cells and hepatoma cells. Administered to the cells is an isolated and purified protein derived from Bacillus thuringiensis subspecies thuringiensis, having a molecular weight of approximately 20 Kda as determined by SDS-PAGE.
Canada Application No. 2,234,794 Filing Date 05/31/1996
China Patent No. ZL96196036.1.Granted 04/07/2004
Switzerland Patent No.0835260. Granted 10/30/2002
Germany Patent No.0835260. Granted 10/30/2002
Spain Patent No.0835260. Granted 10/30/2002
France Patent No.0835260. Granted 10/30/2002
United Kingdom Patent No.0835260. Granted 10/30/2002
United States of America Application No. 08/454,636 Filing DATE 05/31/1995
United States of America Patent No. 5,824,636 10/20/1998
Patent Cooperation Treaty. PCT/US96/08189 Filing Date 05/31/1996
Sout Africa 96/4359. Granted 07/29/1998
Patente Internacional. PCT/EP2019/080366.
Tittle: SYNTHETIC PEPTIDES INDUCING IMMUNOGENIC CELL DEATH. Francia. 06/11/2019.
Solicitud de Patente Internacional No. PCT/MX2007/000120 “ANTÍGENO MODIFICADO PARA DETECCIÓN DE ANTICUERPOS CONTRA BRUCELLA Y MÉTODOS DE USO.”Está en examen preliminar internacional en la Oficina Española de Patentes y Marcas.
Pedro de Alba s / n. Ciudad Universitaria, A.P. 124 - F C.P. 66451 San Nicoláss de los Garza, Nuevo León, México
T. 83.29.41.15 / 83.76.43.19 / Fax. 83.52.42.12